BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Diagnosis
36 results:

  • 1. Perceptions and experiences of fertility preservation in female patients with cancer in Greece.
    Taniskidou AM; Voultsos P; Tarlatzis V; Timotheadou E
    BMC Womens Health; 2024 Feb; 24(1):108. PubMed ID: 38336757
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fertility preservation before and after cancer treatment in children, adolescents, and young adults.
    Yang EH; Strohl HB; Su HI
    Cancer; 2024 Feb; 130(3):344-355. PubMed ID: 37962199
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Do Fertility Preservation Outcomes in Patients Diagnosed with Lymphoma Differ Based on cancer Stage?
    Kocsuta V; Shah S; Lawson AK; Pavone ME
    J Adolesc Young Adult Oncol; 2024 Apr; 13(2):300-306. PubMed ID: 36809174
    [No Abstract]    [Full Text] [Related]  

  • 4. Fertility Preservation Practices at Pediatric Oncology Institutions in the United States: A Report From the Children's Oncology Group.
    Frederick NN; Klosky JL; Meacham L; Quinn GP; Kelvin JF; Cherven B; Freyer DR; Dvorak CC; Brackett J; Ahmed-Winston S; Bryson E; Su HI; Chow EJ; Levine J
    JCO Oncol Pract; 2023 Apr; 19(4):e550-e558. PubMed ID: 36763922
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oocyte vitrification for fertility preservation following COS does not delay the initiation of neoadjuvant chemotherapy for breast cancer compared to IVM.
    Sellami I; Mayeur A; Benoit A; Zeghari F; Peigné M; Roufael J; Grynberg M; Sonigo C
    J Assist Reprod Genet; 2023 Mar; 40(3):473-480. PubMed ID: 36752941
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Incidence of fertility preservation procedures in prepubertal individuals with cancer.
    Ory J; Nassau D; Rodriguez CD; Sathe A; Nackeeran S; Manda P; Reddy A; Romao RL; Ramasamy R
    J Pediatr Urol; 2022 Oct; 18(5):681.e1-681.e6. PubMed ID: 36207267
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The risk of menopausal symptoms in premenopausal breast cancer patients and current pharmacological prevention strategies.
    Lei YY; Yeo W
    Expert Opin Drug Saf; 2021 Oct; 20(10):1163-1175. PubMed ID: 33951990
    [No Abstract]    [Full Text] [Related]  

  • 8. Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG).
    Geoffron S; Lier A; de Kermadec E; Sermondade N; Varinot J; Thomassin-Naggara I; Bendifallah S; Daraï E; Chabbert-Buffet N; Kolanska K
    Gynecol Oncol; 2021 Jun; 161(3):817-824. PubMed ID: 33812696
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fertility preservation for cancer patients: treatment gaps and considerations in patients' choices.
    Kappy M; Lieman HJ; Pollack S; Buyuk E
    Arch Gynecol Obstet; 2021 Jun; 303(6):1617-1623. PubMed ID: 33544203
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Does type of cancer affect ovarian response in oncofertility patients?
    Hussein RS; Zhao Y; Khan Z
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101944. PubMed ID: 33069914
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
    D'Hondt C; Vanhoeij M; Van Moer E; Segers I; Fontaine C; Tournaye H; De Vos M
    Breast Cancer Res Treat; 2020 Nov; 184(2):433-444. PubMed ID: 32794060
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of tumor size on the accuracy of frozen section in the evaluation of mucinous borderline ovarian tumors.
    Karataşlı V; Can B; Çakır İ; Erkılınç S; Karabulut A; Ayaz D; Kuru O; Gökçü M; Sancı M
    J Gynecol Obstet Hum Reprod; 2020 Jun; 49(6):101765. PubMed ID: 32325272
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oncofertility Treatment Among Breast cancer Women: A Paradigm Shift of Practice After a Decade of Service.
    Ahmad MF; Sugishita Y; Suzuki-Takahashi Y; Sawada S; Iwahata H; Shiraishi E; Takae S; Horage-Okutsu Y; Suzuki N
    J Adolesc Young Adult Oncol; 2020 Aug; 9(4):496-501. PubMed ID: 32283045
    [No Abstract]    [Full Text] [Related]  

  • 15. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
    Vriens IJH; Ter Welle-Butalid EM; de Boer M; de Die-Smulders CEM; Derhaag JG; Geurts SME; van Hellemond IEG; Luiten EJT; Dercksen MW; Lemaire BMD; van Haaren ERM; Vriens BEPJ; van de Wouw AJ; van Riel AMGH; Janssen-Engelen SLE; van de Poel MHW; Schepers-van der Sterren EEM; van Golde RJT; Tjan-Heijnen VCG
    Breast Cancer Res Treat; 2020 May; 181(1):77-86. PubMed ID: 32236826
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Role of
    Budak E; Yanarateş A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):14-19. PubMed ID: 31744788
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation.
    Vergier J; Bottin P; Saias J; Reynaud R; Guillemain C; Courbiere B
    Clin Endocrinol (Oxf); 2019 Nov; 91(5):646-651. PubMed ID: 31420888
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Patterns of Referral for Fertility Preservation Among Female Adolescents and Young Adults with Breast cancer: A Population-Based Study.
    Korkidakis A; Lajkosz K; Green M; Strobino D; Velez MP
    J Adolesc Young Adult Oncol; 2019 Apr; 8(2):197-204. PubMed ID: 30676852
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Psychosocial benefits of fertility preservation for young cancer patients.
    Assi J; Santos J; Bonetti T; Serafini PC; Motta ELA; Chehin MB
    J Assist Reprod Genet; 2018 Apr; 35(4):601-606. PubMed ID: 29435699
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
    Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
    Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.